Pharmacokinetics, pharmacodynamics, and safety of single-dose subcutaneous sarilumab with or without methotrexate in Japanese patients with rheumatoid arthritis: Two single-dose studies

Tomonori Ishii(Tohoku University), Toshiya Takahashi(Tohoku University), Christine Xu(Sanofi (United States)), Miyuki Kajiwara(Sanofi (Japan)), Yukio Sato(Imperial Household Agency), Naoto Kato(Jichi Medical University), Hubert van Hoogstraten(Sanofi (United States)), Yasuhiko Munakata(Tohoku University), Yoshinori Takahashi(Sanofi (Japan))
Modern Rheumatology
April 21, 2022
Cited by 1


Related Papers